1. Home
  2. TEVA vs TSN Comparison

TEVA vs TSN Comparison

Compare TEVA & TSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • TSN
  • Stock Information
  • Founded
  • TEVA 1901
  • TSN 1935
  • Country
  • TEVA Israel
  • TSN United States
  • Employees
  • TEVA N/A
  • TSN N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • TSN Meat/Poultry/Fish
  • Sector
  • TEVA Health Care
  • TSN Consumer Staples
  • Exchange
  • TEVA Nasdaq
  • TSN Nasdaq
  • Market Cap
  • TEVA 21.2B
  • TSN 19.7B
  • IPO Year
  • TEVA N/A
  • TSN N/A
  • Fundamental
  • Price
  • TEVA $23.62
  • TSN $52.61
  • Analyst Decision
  • TEVA Strong Buy
  • TSN Hold
  • Analyst Count
  • TEVA 7
  • TSN 10
  • Target Price
  • TEVA $25.57
  • TSN $62.30
  • AVG Volume (30 Days)
  • TEVA 11.7M
  • TSN 2.5M
  • Earning Date
  • TEVA 11-05-2025
  • TSN 11-10-2025
  • Dividend Yield
  • TEVA N/A
  • TSN 3.87%
  • EPS Growth
  • TEVA N/A
  • TSN N/A
  • EPS
  • TEVA 0.62
  • TSN 2.20
  • Revenue
  • TEVA $16,776,000,000.00
  • TSN $54,146,000,000.00
  • Revenue This Year
  • TEVA $4.11
  • TSN $3.67
  • Revenue Next Year
  • TEVA $0.40
  • TSN $2.34
  • P/E Ratio
  • TEVA $39.86
  • TSN $23.52
  • Revenue Growth
  • TEVA 0.02
  • TSN 1.99
  • 52 Week Low
  • TEVA $12.47
  • TSN $50.56
  • 52 Week High
  • TEVA $25.00
  • TSN $65.95
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 78.31
  • TSN 46.23
  • Support Level
  • TEVA $20.11
  • TSN $51.82
  • Resistance Level
  • TEVA $25.00
  • TSN $52.85
  • Average True Range (ATR)
  • TEVA 0.67
  • TSN 0.92
  • MACD
  • TEVA 0.52
  • TSN 0.14
  • Stochastic Oscillator
  • TEVA 86.29
  • TSN 56.16

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About TSN Tyson Foods Inc.

Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, each composing about one third of US sales. Prepared foods constituted 18% of fiscal 2024 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.

Share on Social Networks: